Ketone body metabolism + exogenous ketones

Category: biosynthesis

Overview

Ketogenesis (cross-link: ketone_body_synthesis) produces β-hydroxybutyrate (BHB), acetoacetate, and minor acetone under low-insulin / high-fatty-acid flux states. BHB is the dominant circulating ketone, metabolized in brain + heart + muscle to acetyl-CoA → TCA via BDH1 + SCOT (succinyl-CoA-3-ketoacid CoA transferase — absent in liver, which prevents the liver from oxidizing its own ketones). Exogenous ketone supplements bypass dietary keto: (1) BHB salts (Na/K/Ca/Mg-BHB) raise BHB to ~0.5-1 mM (sub-physiologic vs 1-5 mM with strict keto diet); (2) Ketone esters (HVMN Ketone-IQ / ΔG / 1,3-butanediol diester) achieve 2-4 mM. Claims: cognitive enhancement, endurance, neuroprotection, weight loss adjunct. Long-term clinical outcome data limited; mechanism plausible via mitochondrial uncoupling + HDAC inhibition + GPR109A signaling.

Organ Systems

Pathway Steps

  1. acetyl-coa → beta-hydroxybutyrate — via HMG-CoA synthase + HMG-CoA lyase + BDH1 (hepatic ketogenesis); cross-link: ketone_body_synthesis. Hepatic ketogenesis (HMG-CoA synthase → HMG-CoA lyase → BDH1) runs when fasting/low-carb states flood mitochondria with acetyl-CoA while oxaloacetate is diverted to gluconeogenesis. The liver lacks SCOT, so it exports but cannot itself use ketones.
  2. beta-hydroxybutyrate → acetyl-coa — via BDH1 + SCOT (extrahepatic tissues) → TCA. Extrahepatic tissues (brain, heart, muscle) reactivate ketones via BDH1 then SCOT (succinyl-CoA:3-ketoacid CoA transferase) to acetyl-CoA for the TCA cycle. The brain shifts to ketones for most of its fuel in prolonged fasting, sparing glucose and muscle protein.

Known Modulators

References